Search
Selected: O

Ophthalmic compositions for treating ocular hypertension

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic compositions for treating ocular hypertension

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic formulation for treating myopia comprising dopamine a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic formulation which modulates dilation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic formulation which modulates dilation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic NSAID formulations containing a quaternary ammonium p

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic pharmaceutical compositions and methods for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic pharmaceutical compositions comprising a nitrone comp

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic pranoprofen compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic solution

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic topical agent for remedy of diseases of iris and cili

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic use of muscarinic agonists having increased duration

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic use of naphthyridine antibiotics

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic use of norfloxacin and related antibiotics

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic uses of PPARgamma agonists and PPARgamma antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic viscoelastic compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmic wound healing with aldose reductase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ophthalmological preparation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Opiate agonists and antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Opiate agonists and antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.